ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Highlights from the New England Journal of Medicine: editors’ choice
Event:
ESC CONGRESS 2019
Topic:
European Society of Cardiology, Other
Session type:
Symposium
Date:
1 September 2019
Time:
11:00 - 12:10
Session
0
3
presentations
in this session
Novel Therapeutic Agents for Transthyretin Amyloidosis – Represented in NEJM by the ATTR-ACT, APOLLO, and NEURO-TTR trials.
Speaker:
Professor C. Rapezzi (Ferrara, IT)
Access
Slides
Video
0
Aspirin for the Primary Prevention of Cardiovascular Disease – Represented in NEJM by the ASPREE and ASCEND trials (and in Lancet by the ARRIVE trial).
Speaker:
Professor J. Mcneil (Melbourne, AU)
Access
Slides
Video
0
Transcatheter Aortic Valve Replacement in Low-Risk Patients – Represented in NEJM by the PARTNER 3 and Evolut Low Risk trials.
Speaker:
Doctor M. Mack (Dallas, US)
Access
Slides
Video
0
3
speakers
from this session
Professor Claudio Rapezzi
University of Ferrara, Ferrara (Italy)
26
presentations
0
follower
Professor John Mcneil
Monash university, Melbourne (Australia)
2
presentations
0
follower
Doctor Michael Mack
Baylor Scott & White Health, Dallas (United States of America)
3
presentations
0
follower
This platform is supported by